Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New XFp Analyzer from Seahorse Bioscience
Wednesday, June 25, 2014
Makes measuring metabolism affordable for every lab.

VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif
Tuesday, June 24, 2014
First revenues from VolitionRx Nucleosomics technology.

Tecan Unveils Fluent™ Laboratory Automation Solutions
Tuesday, June 24, 2014
Tecan has introduced the Fluent™ laboratory automation solution, the latest addition to its world-class laboratory automation portfolio.

Agilent Introduces Novel Synthetic Biology System
Saturday, June 21, 2014
QuikChange HT system accelerates protein engineering.

Bioo Scientific Releases Sciclone and Biomek Protocols
Saturday, June 21, 2014
Protocols designed to eliminate NGS library prep bottlenecks.

Hudson Robotics Announces the Release of New White Paper
Friday, June 20, 2014
Company’s new research reveals optimal settings for multi-channel pipettors.

DNASTAR Releases Lasergene 12 Software
Thursday, June 19, 2014
Lasergene 12 improves sequence alignments and NGS accuracy.

High Volume Microplates
Thursday, June 12, 2014
24-well deep well plates maximizes both productivity and operational flexibility.

Quest Diagnostics Introduces bioMerieux THxID®-BRAF Test
Wednesday, June 11, 2014
A companion diagnostic to advance precision medicine for melanoma.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 2541
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv